(Q35125667)

6 August 2017

title

Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients (English)

1 reference

6 August 2017

Elective Bowel Resection for Incurable Stage IV Colorectal Cancer: Prognostic Variables for Asymptomatic Patients (English)

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00136-4

1 January 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00136-4

1 January 2024

author name string

Leyo Ruo

1

1 reference

6 August 2017

Christina Gougoutas

2

1 reference

6 August 2017

Philip B. Paty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742204

1 January 2024

Jose G. Guillem

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742204

1 January 2024

Alfred M. Cohen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742204

1 January 2024

W. Douglas Wong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742204

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12742204

1 January 2024

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S1072751503001364?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00136-4

https://api.elsevier.com/content/article/PII:S1072751503001364?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00136-4

https://journals.lww.com/00019464-200305000-00011

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00136-4

Journal of the American College of Surgeons

1 January 2024

published in

1 reference

6 August 2017

volume

196

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

722-728

1 reference

Operation in patients with incurable colon cancer--is it worthwhile?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Nonoperative management of primary colorectal cancer in patients with stage IV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Initial presentation with stage IV colorectal cancer: how aggressive should we be?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Answering patients' needs: oral alternatives to intravenous therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Radiation treatment for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900136-4

7 January 2021

Identifiers

1 reference

6 August 2017

1 reference